Adams Jennifer McKie
SEC Form 4 insider trading activity
Adams Jennifer McKie has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Jun 17, 2026.
On the most recent filing, Adams Jennifer McKie is listed as Director at Eton Pharmaceuticals, Inc. Inside the rolling window, Adams Jennifer McKie reported no open-market purchases and 1 open-market sale totaling $1.6M in ETON.
Companies traded
Other insiders at ETON
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.6M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Adams Jennifer McKie made?
Adams Jennifer McKie has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company since 2026.
Which companies does Adams Jennifer McKie trade?
Adams Jennifer McKie has filed SEC Form 4 disclosures for 1 company, including ETON.
When was Adams Jennifer McKie's most recent SEC Form 4 filing?
Adams Jennifer McKie's most recent SEC Form 4 filing on Tracefour is dated Jun 17, 2026.
What is Adams Jennifer McKie's total buy and sell value in the current window?
Inside the rolling retention window, Adams Jennifer McKie bought $0 and sold $1.6M based on SEC Form 4 filings.
What was Adams Jennifer McKie's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 50,000 ETON shares on 2026-06-17, worth $1.6M, per SEC Form 4 filings.